Angiogeney, Inc.
8Patents
4Active
8Granted
36Portfolio score
Filing activity: Nov 26, 1996 → Mar 10, 2009 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6626928B1 | Occlusion device for treating aneurysm and use therefor | Human Necessities | 60 | Expired |
| US8138356B2 | Chemical inhibitors of inhibitors of differentiation | Human Necessities | 12 | Active |
| US5821354A | Radiolabeled DNA oligonucleotide and method of preparation | Human Necessities | 1 | Expired |
| US7608698B2 | Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions | Human Necessities | 0 | Expired |
| US8088893B2 | Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions | Human Necessities | 0 | Active |
| US6339071B1 | Antisense oligonucleotide modulating cyclin E gene expression and therapeutic uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US7517663B2 | Rabbit monoclonal antibody against Id1 protein | Chemistry; Metallurgy | 0 | Active |
| US7629131B2 | Rabbit monoclonal antibodies against mouse/human Id3 proteins | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.